China News Service, June 12, according to India's New Delhi Television (NDTV) reported on the 11th, in the past three weeks, the reported cases of mucor mold infection in various parts of India increased by more than 150% to 31216 cases and 2109 deaths.
According to reports, India’s new crown epidemic continues to spread. Now, the country’s medical system is facing new challenges, that is, the number of mucormycosis infections among patients with new crown is increasing.
According to reports, Maharashtra has 7057 cases of mucor and 609 deaths, which are higher than other states; Gujarat is followed by 5418 cases of mucor and 323 deaths.
The report pointed out that the rapid spread of the disease was partly due to the severe shortage of the key drug "Amphotericin B".
Indian health experts call mucormycosis an "epidemic disease", caused by the "mucor mold" fungus that exists in the natural environment. New crown patients with diabetes are susceptible to infection with the bacteria after hormone therapy, and their symptoms are headaches. , Nose bleeding, hemoptysis, facial numbness and swelling, blurred vision, difficulty breathing, etc., have a high fatality rate.
According to the media, the overall mortality rate of mucormycosis is as high as 50%.